Evidence map›Paper›PMID 22203674›Full record

ArticleThe Journal of biological chemistry2012

Mechanism of MTA1 protein overexpression-linked invasion: MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and function.

Deivendran Sankaran, Suresh B Pakala, Vasudha S Nair, Divijendra Natha Reddy Sirigiri, Dinesh Cyanam, Ngoc-Han Ha, Da-Qiang Li, T R Santhoshkumar, M Radhakrishna Pillai, Rakesh Kumar

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Deivendran SankaranIntegrated Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India.
Suresh B Pakala
Vasudha S Nair
Divijendra Natha Reddy Sirigiri
Dinesh Cyanam
Ngoc-Han Ha
Da-Qiang Li
T R Santhoshkumar
M Radhakrishna Pillai
Rakesh Kumar
George Washington University · USRajiv Gandhi Centre for Biotechnology · INWashington University Medical Center · US

Funding

Role of Metastatic Tumor Antigen-1 in Mammary GlandR01CA098823 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KUMAR, RAKESH · 2003 to 2013
$3.1M
Acquisition of Zeiss 710 Confocal Laser Scanning MicroscopeS10RR025565 · NCRR · GEORGE WASHINGTON UNIVERSITY · PI POPRATILOFF, ANASTAS · 2009 to 2009
$500k
NCI NIH HHS CA98823NCI NIH HHS R01 CA098823NCRR NIH HHS S10 RR025565NCRR NIH HHS S10RR025565
6 · The paper itself

Abstract

Even though the hyaluronan-mediated motility receptor (HMMR), a cell surface oncogenic protein, is widely up-regulated in human cancers and correlates well with cell motility and invasion, the underlying molecular and nature of its putative upstream regulation remain unknown. Here, we found for the first time that MTA1 (metastatic tumor antigen 1), a master chromatin modifier, regulates the expression of HMMR and, consequently, its function in breast cancer cell motility and invasiveness. We recognized a positive correlation between the levels of MTA1 and HMMR in human cancer. Furthermore, MTA1 is required for optimal expression of HMMR. The underlying mechanism includes interaction of the MTA1·RNA polymerase II·c-Jun coactivator complex with the HMMR promoter to stimulates its transcription. Accordingly, selective siRNA-mediated knockdown of HMMR in breast cancer cells substantially reduces the invasion and migration of cells. These findings reveal a regulatory role for MTA1 as an upstream coactivator of HMMR expression and resulting biological phenotypes.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingCell Line, TumorCell MovementExtracellular Matrix ProteinsFemaleHistone DeacetylasesHumansHyaluronan ReceptorsJNK Mitogen-Activated Protein KinasesMiceNeoplasm InvasivenessRepressor ProteinsRNA Polymerase IIExtracellular Matrix ProteinsHistone Deacetylaseshyaluronan-mediated motility receptorHyaluronan ReceptorsJNK Mitogen-Activated Protein KinasesMTA1 protein, humanRepressor ProteinsRNA Polymerase IITrans-Activators

Identifiers

PMID22203674
PMCPMC3285325
OpenAlexW2104424042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.